Forecast & Rating3 analysts currently cover Moleculin Biotech, of which 3 give a positive rating. The average price target is $12.00, about 1452.2% upside from the current price of $0.77. Coverage is limited, so the data is for reference only. Data as of Sep 1, 2026; this does not constitute investment advice.
Aug 28, 2026Price forecast
$12.001452.19%
Forecast & RatingStrong buy
3analysts
- Strong buy66.67%
- Buy33.33%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
Target price forecast
Forecast dateSep 14, 2026
Forecast met0.0%
Stock price$0.77
Avg. target$24.3
High target$31
Low target$20
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.